量化瘤细胞在中心离心性痕脱发症中
Sydney Look-Why1, Jared Goldberg2, Claire Alexanian3
1Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
JAAD international
|February 19, 2024
概括
乳头细胞 (MCs) 在被CD117.7染色时,在中心离心性性脱毛 (CCCA) 中更为普遍. 麦克细胞计数与炎症和纤维化相关,这表明治疗白的治疗潜力.
科学领域:
- 皮肤病学 皮肤病学
- 病理学 病理学 病理学
- 免疫组织化学 免疫组织化学
背景情况:
- 巨细胞 (MCs) 在淋巴细胞痕性脱光症中越来越多地被识别出来.
- 在中心离心性白 (CCCA) 中MCs的作用仍然未被研究.
研究的目的:
- 在CCCA活检中调查MCs的存在和数量.
- 为了将MC计数与CCCA的基因病理和临床特征相关联.
- 为了比较CD117和Giemsa染料在CCCA中MC检测的疗效.
主要方法:
- 对CCCA患者活检的回顾性审查.
- 使用Giemsa染色和CD117免疫氧化酶染色来量化MCs.
- 与毛囊数,炎症,纤维化,疾病严重程度和持续时间的相关性分析.
主要成果:
- CD117染色产生了显著更高的MC计数比Giemsa染色.
- 包括峡谷水平增加了MC检测.
- CD117检测到的MC与炎症有显著的相关性.
- 两种染色的MC计数都与纤维化有显著的关联,独立于其他因素.
结论:
- 乳腺母细胞存在于CCCA中,它们的数量与关键的病理特征相关.
- 在CCCA中,CD117免疫染在MC检测方面优于Giemsa.
- 这些发现表明CCCA和相关的痕性脱发症的潜在治疗点.
更多相关视频
08:25An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
2.4K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
相关概念视频
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...